Immunology and Microbiology
Allele
10%
Antibiotic Sensitivity
23%
Antimicrobial Peptides
23%
Antimicrobial Resistance
48%
Bactericidal Activity
10%
Bacteriophage
16%
Biofilm
12%
Broth Dilution
12%
Cell Membrane
36%
Colony Forming Unit S
16%
Colony-Forming Unit
18%
Drug Megadose
15%
Endocarditis
37%
Endocardium
10%
Enterobacterales
30%
Enterococcus
64%
Enterococcus faecalis
86%
Enterococcus faecium
100%
Enterococcus gallinarum
12%
Escherichia coli
14%
Etest
13%
Gene Cluster
10%
Glycopeptide
14%
Infectious Agent
37%
Inoculum
47%
Klebsiella pneumoniae
23%
Lineage
26%
Methicillin Susceptible Staphylococcus Aureus
38%
Methicillin-Resistant Staphylococcus Aureus
55%
Minimum Inhibitory Concentration
65%
Molecular Epidemiology
14%
Penicillin
11%
Penicillin Binding Protein
11%
Peptidoglycan
11%
Peritonitis
12%
Pharmacodynamics
10%
Phylogenomics
14%
Plasmid
19%
Prevalence
21%
Promoter Region
11%
Pseudomonas aeruginosa
26%
Rat Model
10%
Staphylococcus aureus
45%
Stenotrophomonas maltophilia
9%
Streptococcus Mitis
15%
Streptococcus pneumonia
9%
Vancomycin Resistance
22%
Vancomycin-Resistant Enterococcus
53%
Whole Genome Sequencing
44%
Wild Type
11%
Pharmacology, Toxicology and Pharmaceutical Science
Aminoglycoside
6%
Ampicillin
16%
Antibiotics
23%
Antiinfective Agent
20%
Antimicrobial Resistance
31%
Bacterial Endocarditis
20%
Bloodstream Infection
47%
Carbapenem
13%
Cardiolipin
7%
Ceftaroline
10%
Ceftolozane
6%
Ceftriaxone
13%
Cohort Study
8%
Combination Therapy
10%
Daptomycin
81%
Diseases
7%
Endocarditis
20%
Enterococcal Infection
13%
Enterococcus
31%
Enterococcus faecalis
32%
Enterococcus faecium
46%
Epidemiology
6%
Gentamicin
5%
Infection
42%
Infectious Agent
21%
Lactam
7%
Linezolid
24%
Malignant Neoplasm
5%
Methicillin Susceptible Staphylococcus Aureus
6%
Methicillin-Resistant Staphylococcus Aureus
23%
Minimum Inhibitory Concentration
6%
Monotherapy
6%
Pharmacodynamics
10%
Pharmacokinetic
8%
Phospholipid
6%
Prevalence
6%
Prospective Cohort Study
9%
Pseudomonas aeruginosa
7%
Rat Model
9%
Soft Tissue Infection
6%
Staphylococcus aureus
19%
Streptococcus Group A
6%
Streptococcus Mitis
6%
Synthetase
7%
Vancomycin
32%
Vancomycin-Resistant Enterococcus
37%
Keyphrases
30-day Mortality
6%
Adaptation
7%
Ampicillin
11%
Antibacterial Resistance
6%
Antibiotics
19%
Antimicrobial
14%
Antimicrobial Peptides
9%
Antimicrobial Resistance
8%
Bacteremia
10%
Bloodstream Infection
9%
Carbapenem-resistant Enterobacterales
12%
Cardiolipin Synthase
7%
Cefazolin
8%
Cefazolin Inoculum Effect
16%
Cefiderocol
6%
Cell Membrane
11%
Colombia
13%
COVID-19
10%
Daptomycin
67%
Daptomycin Resistance
13%
E. Faecalis
13%
Endocarditis
9%
Enterococcal Endocarditis
6%
Enterococcal Infections
7%
Enterococcus
26%
Enterococcus Faecalis
33%
Enterococcus Faecium
36%
High Inoculum
8%
Increased Mortality
6%
Infective Endocarditis
15%
Inoculum Effect
9%
Lactams
6%
Latin America (LATAM)
6%
LiaFSR
19%
Liar
11%
Methicillin-resistant Staphylococcus Aureus
31%
Monotherapy
8%
Nitrocefin
7%
Patients with Cancer
9%
Rat Model
6%
Risk Factors
7%
Staphylococcus Aureus Bloodstream Infection
10%
Tedizolid
6%
VanA
6%
VanA Gene
6%
Vancomycin
13%
Vancomycin Resistance
14%
Vancomycin-resistant Enterococci
11%
Whole Genome Sequencing
7%
β-lactamase
10%